Skip to main content

Eton Pharmaceuticals, Inc.

ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001710340

In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.

Superinvestors holding ETON, Q2 2026

See all superinvestors

No superinvestor reported holding ETON in Q2 2026.